Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, a medicine currently in development may delay the worsening of liver cancer. The medicine is an oral signal transduction inhibitor that targets proteins involved in tumor cell proliferation and angiogenesis.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • After one year, 73 percent of non-small-cell lung cancer patients with the EGFR genetic mutation who were treated with a tyrosine kinase inhibitor had survived, compared to 15 percent who…  
  • Survival rates for colon cancer went from 41 percent to 63 percent between 1975 and 1995.  
  • The 5-year survival rate for all cancers diagnosed between 1995 and 2001 is up from 50% in 1974-1976 to 65%.  
  • For women age 40 or older, timely mammograms could reduce breast cancer mortality by about 16%–compared to those who are not screened.  
  • Without screening and adjuvant therapy, the death rate for breast cancer would have increased by about 30 percent between 1975 and 2000.